Metrics as of 10/15/2026, 10:08 AM (Berlin time), refresh in progress.
KP Tissue Stock
KP Tissue Inc.
Company data
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- Canada
- CEO
- Dino J. Bianco
- Employees
- 2,700
- Market cap
- $116 M
- IPO
- 13/12/2012
KP Tissue Inc. conducts its core operations through its investment in Kruger Products L.P., focusing on the creation, dissemination, and sale of a diverse range of disposable tissue products throughout Canada and the United States. The company divides its business into two primary segments: Consumer and…
KP Tissue stock: price history
1D
-1.1%
1W
+1.1%
1M
-9.0%
6M
+2.7%
YTD
+12.9%
1Y
+24.0%
2Y
+39.7%
5Y
+12.5%
10Y
-19.1%
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~12% weaker price swings than usual
Ask the agents about KP Tissue
KP Tissue stock metrics
P/E
12.99
P/B
1.63
EV/EBITDA
0.68
RETURN ON EQUITY
3.1%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
6.7%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
99.3%
FLOAT SHARES
9,959,753
AVG. DAILY VOLUME (30D)
17,387
Dividends
Comparable stocks
Frequently asked questions about KP Tissue stock
What does KP Tissue do?
KP Tissue Inc. is a company in the Consumer Defensive sector, Household & Personal Products industry, headquartered in Canada.
The CEO is Dino J. Bianco, the company employs around 2,700 people.
The IPO was on 13/12/2012; the stock trades on TSX under the ticker KPT.TO.
When does KP Tissue report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly -12% stronger than usual.
Does KP Tissue pay a dividend?
Yes. The last dividend was CA$0.21 per share, ex-date 29/09/2026, paid on 15/10/2026.
The dividend yield is 6.7% (as of 31/03/2026).
Which stocks are comparable to KP Tissue?
Comparable stocks include Procter & Gamble Company, Colgate-Palmolive Company, Estée Lauder Companies, Kenvue, Kimberly-Clark, Henkel, Church & Dwight and Beiersdorf.
How can I get KP Tissue stock analyzed?
Clicking "Analyze stock" lets five strategies assess KP Tissue against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.